Open-Label Safety and Tolerability Study of INCB057643 in Subjects With Advanced Malignancies
Incyte Corporation
Incyte Corporation
Pfizer
EMD Serono
University of Virginia
Bayer
OHSU Knight Cancer Institute
Bristol-Myers Squibb
National Institute of Allergy and Infectious Diseases (NIAID)
M.D. Anderson Cancer Center
Tocagen Inc.
Vanderbilt-Ingram Cancer Center
AHS Cancer Control Alberta
Columbia University
Masonic Cancer Center, University of Minnesota
OHSU Knight Cancer Institute
OHSU Knight Cancer Institute
OHSU Knight Cancer Institute
Rutgers, The State University of New Jersey
M.D. Anderson Cancer Center
City of Hope Medical Center
Vanderbilt University
Duke University
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Case Comprehensive Cancer Center
Pediatric Brain Tumor Consortium
Case Comprehensive Cancer Center